Denosumab treatment lapses, discontinuation, and off-treatment fracture risk: A retrospective study of patients with osteoporosis in a real-world clinical setting
Katie R. Cruchelow, Megan E. Peter, Anwesa Chakrabarti, Hannah M. Gipson, W. Taylor Gregory, Josh DeClercq, Leena Choi, S. Bobo Tanner
Topics & Concepts
DiscontinuationMedicineDenosumabInterquartile rangeRetrospective cohort studyProportional hazards modelHazard ratioBody mass indexPediatricsInternal medicineOsteoporosisSurgeryEmergency medicineConfidence intervalBone health and osteoporosis researchBone health and treatmentsBone Metabolism and Diseases